ClinVar Miner

Submissions for variant NM_005591.4(MRE11):c.1444_1445del (p.Gln482fs)

dbSNP: rs1245161888
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001011611 SCV001171953 pathogenic Hereditary cancer-predisposing syndrome 2022-03-15 criteria provided, single submitter clinical testing The c.1444_1445delCA pathogenic mutation, located in coding exon 12 of the MRE11A gene, results from a deletion of two nucleotides at nucleotide positions 1444 to 1445, causing a translational frameshift with a predicted alternate stop codon (p.Q482Afs*4). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Invitae RCV001386114 SCV001586230 pathogenic Ataxia-telangiectasia-like disorder 2023-07-31 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 819233). This variant has not been reported in the literature in individuals affected with MRE11-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Gln482Alafs*4) in the MRE11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MRE11 are known to be pathogenic (PMID: 23080121, 23912341).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.